Shen Peicheng, Shen Jiaojiao, Sun Chuan, Yang Xuejun, He Liqun
Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Pudong, Shanghai, 201203, People's Republic of China.
Shanghai Key Laboratory of Traditional Chinese Clinical Medicine (14DZ2273220), Shanghai, People's Republic of China.
BMC Complement Altern Med. 2016 Aug 24;16(1):312. doi: 10.1186/s12906-016-1268-9.
Traditional Chinese medicine (TCM) has been widely used in treating various diseases in eastern Asia for several thousand years, and is becoming increasingly popular in western countries. Gubentongluo (GBTL) decoction, as a classic TCM formula, is commonly applied to treat IgA Nephropathy (IgAN) in China. To date, however, the pharmacological/molecular mechanisms of GBTL have not been fully elucidated.
In the present study, we used a system biological approach to explore these mechanisms acting on IgAN.
First, we found 3876 potential target proteins for GBTL (based on TCMID) and 25 known IgAN associated biomarkers (based on the OMIM or IPA database).16 of the latter biomarkers were direct targets of 6 of the 9 herbs in GBTL, suggesting that these components play a vital role in treating IgAN. Second, we showed that these 6 herbs mainly regulate the immune system and renin-angiotensin system, imbalance in which is the main factor leading to IgAN. Importantly, HUANG QI links with 14 biomarkers, indicating that it is the most important herb in GBTL for treating IgAN. Also, relationships of other herbs with IgAN were explored. Third, we demonstrated that the remaining 9 IgAN associated proteins are responses to biological processes, such as antigen processing, protein ubiquitination and cell cycle regulation, which are crucial for IgAN development. Finally, we found that GBTL could induce a significant increase in the levels of two target gene: TNF and NOS2.
Further studies are called to develop/modify the formula of GBTL, in order to enhance its effect on IgAN.
几千年来,中药在东亚地区被广泛用于治疗各种疾病,并且在西方国家也越来越受欢迎。固本通络(GBTL)汤作为一种经典的中药方剂,在中国常用于治疗IgA肾病(IgAN)。然而,迄今为止,GBTL的药理/分子机制尚未完全阐明。
在本研究中,我们采用系统生物学方法来探索其作用于IgAN的机制。
首先,我们发现了GBTL的3876个潜在靶蛋白(基于中药综合数据库)和25个已知的与IgAN相关的生物标志物(基于在线人类孟德尔遗传数据库或Ingenuity通路分析数据库)。后一组生物标志物中的16个是GBTL中9味草药中6味的直接靶点,表明这些成分在治疗IgAN中起着至关重要的作用。其次,我们表明这6味草药主要调节免疫系统和肾素-血管紧张素系统,该系统的失衡是导致IgAN的主要因素。重要的是,黄芪与14个生物标志物相关联,表明它是GBTL治疗IgAN最重要的草药。此外,还探索了其他草药与IgAN的关系。第三,我们证明了其余9个与IgAN相关的蛋白是对抗原加工、蛋白质泛素化和细胞周期调控等生物过程的反应,这些过程对IgAN的发展至关重要。最后,我们发现GBTL可诱导两个靶基因TNF和NOS2的水平显著升高。
需要进一步研究来开发/修改GBTL的配方,以增强其对IgAN的疗效。